Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Moy, James
One or more keywords matched the following items that are connected to
Moy, James
Item Type
Name
Concept
Antibodies, Neutralizing
Concept
Antibodies
Concept
Antibodies, Viral
Concept
Hepatitis B Antibodies
Academic Article
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Academic Article
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.
Academic Article
Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays.
Academic Article
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests.
Academic Article
Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
Academic Article
Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays.
Academic Article
Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Na?ve and Convalescent BNT162b2 Recipients.
Academic Article
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-na?ve and previously-infected individuals.
Academic Article
Modified ARCHITECT? serologic assays enable plasma-level performance from dried blood spot samples.
Academic Article
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G.
Academic Article
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Search Criteria
Antibodies